105
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical

, , &
Pages 1687-1700 | Published online: 26 Apr 2016

References

  • TanWLiYChenMWangYBerberine hydrochloride: anticancer activity and nanoparticulate delivery systemInt J Nanomedicine201161773177721931477
  • Jabbarzadeh KaboliPRahmatAIsmailPLingKHTargets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancerEur J Pharmacol201474058459524973693
  • TillhonMGuamán OrtizLMLombardiPScovassiAIBerberine: new perspectives for old remediesBiochem Pharmacol2012841260126722842630
  • YeMFuSPiRHeFNeuropharmacological and pharmacokinetic properties of berberine: a review of recent researchJ Pharm Pharmacol20096183183719589224
  • KongWWeiJAbidiPBerberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statinsNat Med2004101344135115531889
  • PundSBoradeGRasveGImprovement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying techniquePhytomedicine20142130731424176841
  • ZhuJXTangDFengLDevelopment of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochlorideDrug Dev Ind Pharm20133949950622563917
  • WangTWangNSongHPreparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberineEur J Pharm Sci20114412713521742030
  • VuddandaPRChakrabortySSinghSBerberine: a potential phytochemical with multispectrum therapeutic activitiesExpert Opin Investig Drugs20101912971307
  • PatilJBKimJJayaprakashaGKBerberine induces apoptosis in breast cancer cells (mcf-7) through mitochondrial-dependent pathwayEur J Pharmacol2010645707820691179
  • HoYTLuCCYangJSBerberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease g in scc-4 human tongue squamous carcinoma cancer cellsAnticancer Res2009294063407019846952
  • BattuSKRepkaMAMaddineniSChittiboyinaAGAveryMAMajumdarSPhysicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral deliveryAAPS PharmSciTech2010111466147520842541
  • LuY-CLinQLuoG-SDaiY-YSolubility of berberine chloride in various solventsJ Chem Eng Data200651642644
  • PanGYWangGJLiuXDFawcettJPXieYYThe involvement of P-glycoprotein in berberine absorptionPharmacol Toxicol20029119319712530470
  • ShitanNTanakaMTeraiKUedaKYazakiKHuman MDR1 and MRP1 recognize berberine as their transport substrateBiosci Biotechnol Biochem20077124224517213652
  • XueMYangMXZhangWCharacterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticlesInt J Nanomedicine201384677468724353417
  • TsaiPLTsaiTHHepatobiliary excretion of berberineDrug Metab Dispos20043240541215039293
  • LiuYTHaoHPXieHGExtensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in ratsDrug Metab Dispos2010381779178420634337
  • LiBXYangBFHaoXMZhouHSunMZStudy on the pharmacokinetics of berberine in single dosage and coadministration with oryzanol in rabbits and healthy volunteersChin Pharm J2000353335
  • WangHLiuDCaoPLeckerSHuZAtrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberineDiabetes2010591879188920522589
  • KheirMMWangYHuaLAcute toxicity of berberine and its correlation with the blood concentration in miceFood Chem Toxicol2010481105111020138204
  • DabholkarRDSawantRMMongaytDADevarajanPVTorchilinVPPolyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of p-glycoprotein-mediated effluxInt J Pharm200631514815716616818
  • TorchilinVPMicellar nanocarriers: pharmaceutical perspectivesPharm Res20072411617109211
  • LukyanovANTorchilinVPMicelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugsAdv Drug Deliv Rev2004561273128915109769
  • WangYFanWDaiXEnhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micellesMol Pharm2014111140115024579673
  • DuhemNDanhierFPréatVVitamin E-based nanomedicines for anti-cancer drug deliveryJ Control Release2014182334424631865
  • MuLElbayoumiTATorchilinVPMixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecinInt J Pharm200530614214916242875
  • SawantRRSawantRMTorchilinVPMixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicityEur J Pharm Biopharm200870515718583114
  • BrownlowBNagarajVJNayelAJoshiMElbayoumiTDevelopment and in vitro evaluation of vitamin E-enriched nanoemulsion vehicles loaded with genistein for chemoprevention against UVB-induced skin damageJ Pharm Sci20151043510352326108889
  • VuddandaPRRajamanickamVMYaspalMSinghSInvestigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticlesBiomed Res Int2014201495194225162037
  • DintamanJMSilvermanJAInhibition of P-glycoprotein by d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)Pharm Res1999161550155610554096
  • ZhangZTanSFengSSVitamin E TPGS as a molecular biomaterial for drug deliveryBiomaterials2012334889490622498300
  • JinYZhangZZhaoTLiuXJianLMixed micelles of doxorubicin overcome multidrug resistance by inhibiting the expression of P-glycoproteinJ Biomed Nanotechnol2015111330133826295136
  • AbouzeidAHPatelNRTorchilinVPPolyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancerInt J Pharm201446417818424440402
  • PhamJGrundmannOElbayoumiTMitochondriotropic nanoemulsified genistein-loaded vehicles for cancer therapyMethods Mol Biol201512658510125634269
  • PhamJBrownlowBElbayoumiTMitochondria-specific pro-apoptotic activity of genistein lipidic nanocarriersMol Pharm2013103789380023992356
  • PhamJNayelAHoangCElbayoumiTEnhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomasDrug Deliv Epub7142015
  • GermaniMDel BeneFRocchettiMVan Der GraafPHA4s: a user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulationComput Methods Programs Biomed201311020321423182621
  • AraújoFAKelmannRGAraujoBVFinattoRBTeixeiraHFKoesterLSDevelopment and characterization of parenteral nanoemulsions containing thalidomideEur J Pharm Sci20114223824521130164
  • BaoLHThe study of pharmacokinetics of berberine after oral administration in humanChin Pharmacol Bull1997139596
  • PatelNRAryasomayajulaBAbouzeidAHTorchilinVPCancer cell spheroids for screening of chemotherapeutics and drug-delivery systemsTher Deliv2015650952025996047
  • PercheFTorchilinVPCancer cell spheroids as a model to evaluate chemotherapy protocolsCancer Biol Ther2012131205121322892843
  • SawantRRTorchilinVPPolymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an exampleMethods Mol Biol201062413114920217593